Genmab A/S (CPH:GMAB)
3,912.00
+124.00 (3.27%)
Oct 30, 2026, 5:00 PM CET
Genmab Employees
Genmab had 3,119 employees as of June 30, 2026. The number of employees increased by 480 or 18.19% compared to the same quarter last year. That makes Genmab the 7,763rd largest employer in the world and 32nd in Denmark.
Employees
3,119
Change (1Y)
480
Growth (1Y)
18.19%
Revenue / Employee
8.67M DKK
Profits / Employee
1.65M DKK
Market Cap
233.76B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 3,119 | 480 | 18.19% |
| Mar 31, 2026 | 3,088 | 450 | 17.06% |
| Dec 31, 2025 | 2,973 | 339 | 12.87% |
| Sep 30, 2025 | 2,681 | 46 | 1.75% |
| Jun 30, 2025 | 2,639 | 113 | 4.47% |
| Mar 31, 2025 | 2,638 | 352 | 15.40% |
| Dec 31, 2024 | 2,634 | 430 | 19.51% |
| Sep 30, 2024 | 2,635 | 503 | 23.59% |
| Jun 30, 2024 | 2,526 | 511 | 25.36% |
| Mar 31, 2024 | 2,286 | 440 | 23.84% |
| Dec 31, 2023 | 2,204 | 544 | 32.77% |
| Sep 30, 2023 | 2,132 | 572 | 36.67% |
| Jun 30, 2023 | 2,015 | 570 | 39.45% |
| Mar 31, 2023 | 1,846 | 537 | 41.02% |
| Dec 31, 2022 | 1,660 | 448 | 36.96% |
| Sep 30, 2022 | 1,560 | 424 | 37.32% |
| Jun 30, 2022 | 1,445 | 416 | 40.43% |
| Mar 31, 2022 | 1,309 | 438 | 50.29% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 66,700 |
| Demant | 26,616 |
| Coloplast | 17,213 |
| GN Store Nord | 7,744 |
| Ambu A/S | 5,200 |
| H. Lundbeck | 5,000 |
| Embla Medical | 4,500 |
| ALK-Abelló | 2,773 |
Genmab News
- 14 hours ago - Genmab price target raised to $57 from $42 at Morgan Stanley - TheFly
- 17 hours ago - Genmab price target raised to $80 from $58 at Guggenheim - TheFly
- 1 day ago - Bicara Therapeutics price target lowered to $24 from $33 at Wedbush - TheFly
- 1 day ago - Genmab price target raised to $70 from $50 at H.C. Wainwright - TheFly
- 2 days ago - Genmab's Three Positive Phase III Readouts Set Stage for Potential 2027 Cancer Launches - MarketBeat
- 2 days ago - Biotech Stocks Rise: GMAB Surges, LUNG And AXGN Gain Over 30% - Nasdaq
- 2 days ago - Genmab Stock (GMAB) Soars Over 30% on Strong Phase 3 Results for Its Head and Neck Cancer Treatment - TipRanks
- 2 days ago - Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50% - Barrons